DIMERIC BISBENZIMIDAZOLES SUPPRESS THE HERPES SIMPLEX VIRUS AND HUMAN CYTOMEGALOVIRUS INFECTIONS IN CELL СULTURES

Cover Page


Cite item

Full Text

Abstract

Antiviral activity of new AТ-specific fluorescent symmetric dimeric bisbenzimidazoles of DBА(n) series was assessed in the cell models of infections caused by type 1 herpes simplex virus (HSV1) and human cytomegalovirus (CMV). In DBA(n) molecules bisbenzimidazole fragments are bound to an oligomethylene liner with varied number of methylene groups in the linker (n = 1, 3, 5, 7, 9, 11). In contrast to DB(n) dimeric bisbenzimidazoles, in DBA(n) series terminal fragments of macromolecules contain N-dimethylaminopropylcarboxamide groups instead of N-methylpiperazine groups. DBА(n) compounds better dissolve in water, pass across plasma and nuclear membrane, and stain DNA in living cells. DBA(1) and DBA(7) produced therapeutic effects in HSV1 infection; DBA(7) completely suppressed the infection. DBA(11) displayed in vitro therapeutic activity in HSV1 and CMV infections. In addition, DBA(7) and DBA(1) showed microbicidal activity. Thus, DBA(11), which is active against two viruses causing severe diseases with serious health consequences for immunodeficient individuals, should be further investigated. High antiviral activity of DBA(7) in all test models indicates that this compound is a promising active agent for innovative antiviral drugs.

About the authors

R. R. Klimova

D.I. Ivanovsky Institute of Virology «Federal Research Center of Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya»

Author for correspondence.
Email: regi.k@mail.ru
Россия

E. D. Momotyuk

D.I. Ivanovsky Institute of Virology «Federal Research Center of Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya»; Skryabin Moscow State Academy of Veterinary Medicine and Biotechnology

Email: noemail@neicon.ru
Россия

N. A. Demidova

Skryabin Moscow State Academy of Veterinary Medicine and Biotechnology

Email: noemail@neicon.ru
Россия

Ya. Yu. Chernoryzh

D.I. Ivanovsky Institute of Virology «Federal Research Center of Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya»

Email: noemail@neicon.ru
Россия

V. S. Koval

Engelhardt Institute of Molecular Biology; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry

Email: noemail@neicon.ru
Россия

A. A. Ivanov

Blokhin Russian Cancer Research Center, Research Institute of Carcinogenesis

Email: noemail@neicon.ru
Россия

A. L. Zhuze

Engelhardt Institute of Molecular Biology

Email: noemail@neicon.ru
Россия

A. A. Kushch

D.I. Ivanovsky Institute of Virology «Federal Research Center of Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya»

Email: noemail@neicon.ru
Россия

References

  1. Looker K.J., Magaret A.S., May M.T., Turner K.M., Vickerman P., Gottlieb S.L. et al. Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012. PLoS One. 2015; 10(10): e0140765.
  2. James S.H., Kimberlin D.W. Neonatal herpes simplex virus infection: epidemiology and treatment. Clin. Perinatol. 2015; 42(1): 47-59.
  3. Barrett M.P., Gemmell C.G., Suckling C.J. Minor groove binders as anti-infective agents. Pharmacol. Ther. 2013; 139: 12-23.
  4. Wilson W. D., Nguyen B., Tanious F. A., Mathis A., Hal J.E., Stephens C.E. et al. Dications that target the DNA minor groove: compound design and preparation, DNA interactions, cellular distribution and biological activity. Curr. Med. Chem. Anticancer. Agents. 2005; 5(4): 389-408.
  5. Мейхи Б. Вирусология. Методы: Пер. с англ. М.: Мир; 1988
  6. Latt S.A. Optical studies of metaphase chromosome organization. Annu. Rev. Biophys. Bioeng. 1976; (5): 1-37.
  7. Teng M.K., Usman N., Frederick C.A., Wang A.H. The molecular structure of the complex of Hoechst 33258 and the DNA dodecamer d(CGCGAATTCGCG). Nucleic. Acids. Res. 1988; (16): 2671.
  8. Vega M.C., Saez I.G., Aymami J., Eritja R., van der Marel G.A., van Boom J.H., et al. Three-dimensional crystal structure of the A-tract DNA dodecamer d(CGCAAATTTGCG) complexed with the minor-groove-binding drug Hoechst 33258. Eur. J. Biochem. 1994; 222: 721.
  9. Chiang S.Y., Welch J.J., Rauscher F.J., Beerman T.A. Effects of minor groove binding drugs on the interaction of TATA box binding protein and TFIIA with DNA. Biochemistry. 1994; (33): 7033-40.
  10. Chiang S.Y., Welch J.J., Rauscher F.J., Beerman T.A. Effect of DNA-binding drugs on early growth response factor-1 and TATA box-binding protein complex formation with the herpes simplex virus latency promoter. J. Biol. Chem. 1996; 271: 23999-4004.
  11. Chen A.Y., Yu C., Gatto B., Liu L.F. DNA minor groove-binding ligands: a different class of mammalian DNA topoisomerase I inhibitors. Proc. Nat. Acad. Sci. USA. 1993; 90: 8131-5.
  12. Zhang X., Zhang S.C., Sun D., Hu J., Wali A., Pass H., et al. New insight into the molecular mechanisms of the biological effects of DNA minor groove binders. PLoS One. 2011; 6(10): e25822.
  13. Woynarowski J.M., McHugh M., Sigmund R.D., Beerman T.A. Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, Hoechst 33258, and 4’,6-diamidine-2-phenylindole. Mol. Pharmacol. 1989; 35: 177-82.
  14. Soderlind K.J., Gorodetsky B., Singh A.K., Bachur N.R., Miller G.G., Lown J.W. Bis-benzimidazole anticancer agents: targeting human tumour helicases. Anticancer. Drug Design. 1999; 14: 19-36.
  15. Martin R.F., Broadhurst S., D’Abrew S., Budd R., Sephton R., Reum M., et al. Radioprotection by DNA ligands. Br. J. Cancer Suppl. 1996; 74(27): 99-101.
  16. Lyubimova N.V., Coutlas P.G., Yuen K., Martin R.F. In vivo radioprotection of mouse brain endothelial cells by Hoechst 33342. Br. J. Radiol. 2001; 74: 77-82.
  17. Сусова О.Ю., Иванов А.А., Моралес Руисс С.С., Лессовая Е.А., Громыко А.В., Стрельцов С.А. и др. Узкобороздочные димерные бисбензимидозолы ингибируют in vitro связывание с ДНК эукариотической ДНК топоизомеразы I. Биохимия. 2010; 75(6): 781-8
  18. Cherepanova N.A., Ivanov A.A., Maltseva D.V., Minero A.S., Gromyko A.V., Streltsov S.A., et al. Dimeric bisbenzimidazoles inhibit the DNA methylation catalyzed by the murine Dnmt3a catalytic domain. J. Enzyme Inhib. Med. Chem. 2011; 26(2): 295-300.
  19. Tunitskaya V.L., Mukovnya A.V., Ivanov A.A., Gromyko A.V., Ivanov A.V., Streltsov S.A., et al. Inhibition of the helicase activity of the HCV NS3 protein by symmetrical dimeric bis-benzimidazoles. Bioorg. Med. Chem. Lett. 2011; 21(18): 5331-5.
  20. Попов К.В., Егорова Е.И., Иванов А.А., Громыко А.В., Жузе А.Л., Большева Н.Л. и др. Димерные бисбензимидозольные красители на основе Hoechst 33258 новые ДНК-специфичные флюорохромы для цитогенетики человека и растений. Биологические мембраны. Журнал мембранной и клеточной биологии. 2008; 25(3): 173-80
  21. Looker K.J., Magaret A.S., Turner K.M., Vickerman P., Gottlieb S.L., Newman L.M. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One. 2015; 10(1): e114989
  22. Климова Р.Р., Малиновская В.В., Гусева Т.С., Паршина О.В., Гетия Е.Г., Дегтярева М.В. и др. Влияние герпесвирусных инфекций на уровень провоспалительных цитокинов у недоношенных новорожденных детей. Вопросы вирусологии. 2011; (4): 23-6
  23. Moore M.D., Bunka D.H., Forzan M., Spear P.G., Stockley P.G., McGowan I., et al. Generation of neutralizing aptamers against herpes simplex virus type 2: potential components of multivalent microbicides. J. Gen. Virol. 2011; 92(7): 1493-9.
  24. Slyker J.A. Cytomegalovirus and paediatric HIV infection. J. Virus Erad. 2016; 2(4): 208-14.
  25. Lichtner M., Cicconi P., Vita S., Cozzi-Lepri A., Galli M., Lo Caputo S., et al. Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. J. Infect. Dis. 2015; 211(Pt. 2): 178-86.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Klimova R.R., Momotyuk E.D., Demidova N.A., Chernoryzh Y.Y., Koval V.S., Ivanov A.A., Zhuze A.L., Kushch A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-77676 от 29.01.2020.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies